Sinovation Ventures led a round for the Fosun-backed medical services platform developer that raised in excess of $14.1m in its series B round.

GV supplied a share of the funding for early learning toy producer Lovevery, which will use the proceeds to expand its product range and functionality.

Intel Capital was among the participants in a round that lifted the total raised by rare disease-focused drug developer Healx to nearly $70m.

The cancer therapy developer boosted a series B round led by Novo and backed by Celgene to $75.2m, with both corporates contributing to the latest tranche.

Legend Capital and Industrial Bank have supplied $70.5m in series B funding for Gambol Pet Group, a pet food manufacturer with operations in Asia, the US and Europe.

Jackson Laboratory cancer drug spinout Cyteir Therapeutics extended its series B round thanks to investors including Osage University Partners and Novo Holdings.

Atomico has led $56m series B round for Cambridge-allied rare disease therapy developer Healx, which also welcomed Intel Capital as a new shareholder.

The SoftBank, Samsung and Megastudy-backed maths tutoring app developer secured $14.5m in a round led by Legend Capital.

Lilly Asia Ventures returned for the respiratory disease drug developer's series B round, having co-led its $85m series A last year.

The Alibaba-backed ETWP Fund led a series B-1 round for XTransfer, which will put the cash towards expanding its cross-border financial services.